Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Medicenna Therapeutics Corp. Common Shares (MDNA)

https://www.medicenna.com

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/07/2017

Market Cap

N/A

Shares Outstanding

69,640,000

Weighted SO

69,637,469

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ACHL --.--%

CKPT --.--%

CUE --.--%

PIRS --.--%

ELYM --.--%

IKNA --.--%

OVID --.--%

CNTB --.--%

EWTX --.--%

Beta

0.7740

Last Div

0.0000

Range

0.1513-0.839

Chg

-0.0238

Avg Vol

260646

Mkt Cap

N/A

Exch

NASDAQ

Country

CA

Phone

416 648 5555

DCF Diff

-0.2230

DCF

0.3800

Div Yield

0.0000

P/S

0.0000

EV Multiple

1.1377

P/FV

0.6390

Div Yield %

0.0000

P/E

-1.0641

PEG

-0.0101

Payout

0.0000

Current Ratio

7.4923

Quick Ratio

7.0346

Cash Ratio

6.9518

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0707

ROA

-0.5073

ROE

-0.4980

ROCE

-0.9391

NI/EBT

1.2152

EBT/EBIT

0.5129

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-9.0622

CF/Debt

0.0000

Equity Multi

1.1837

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.1915

FCF/Share

-0.1915

Cash/Share

0.3689

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.6390

P/B

0.6390

P/S

0.0000

P/E

-1.0641

P/FCF

0.0000

P/OCF

-1.1229

P/CF

-1.1229

PEG

-0.0101

P/S

0.0000

EV Multiple

1.1377

P/FV

0.6390

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Oct 27, 07:55 Medicenna Announces Nasdaq Delisting and Cutback of Management Team

Revenue Product Segmentation